Evidence map›Paper›PMID 39599486›Full record

Observational studyPathogens (Basel, Switzerland)2024

Epidemiology of Bacteremia in Patients with Hematological Malignancies and Hematopoietic Stem Cell Transplantation and the Impact of Antibiotic Resistance on Mortality: Data from a Multicenter Study in Argentina.

Fabián Herrera, Diego Torres, Ana Laborde, Rosana Jordán, Lorena Berruezo, Inés Roccia Rossi, Noelia Mañez, Lucas Tula, María Laura Pereyra, Andrea Nenna and 22 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Fabián HerreraInfectious Diseases Section, Internal Medicine Department, Centro de Educación Médica e Investigaciones Clínicas, (CEMIC), Buenos Aires C1431, Argentina.
Diego TorresInfectious Diseases Section, Internal Medicine Department, Centro de Educación Médica e Investigaciones Clínicas, (CEMIC), Buenos Aires C1431, Argentina.ORCID 0009-0001-3831-4561
Ana LabordeInfectious Diseases Service, Fundación para Combatir la Leucemia (FUNDALEU), Buenos Aires C1114, Argentina.
Rosana JordánInfectious Diseases Service, Hospital Británico de Buenos Aires, Buenos Aires C1280, Argentina.
Lorena BerruezoInfectious Diseases Service, Hospital Interzonal General de Agudos (HIGA) Dr. Rodolfo Rossi, La Plata B1902, Argentina.
Inés Roccia RossiInfectious Diseases Service, Hospital Interzonal General de Agudos (HIGA) Gral. San Martín, La Plata B1900, Argentina.ORCID 0000-0002-3023-9261
Noelia MañezInfectious Diseases Section, Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires C1199, Argentina.ORCID 0009-0008-2413-662X
Lucas TulaInfectious Diseases Service, Hospital El Cruce, Buenos Aires B1888, Argentina.ORCID 0009-0002-2178-3828
María Laura PereyraInfectious Diseases Service, Hospital Universitario Austral, Buenos Aires B1629, Argentina.
Andrea NennaInfectious Diseases Service, Hospital Municipal de Oncología Marie Curie, Buenos Aires C1405, Argentina.ORCID 0000-0002-8131-0339
Patricia CostantiniInfectious Diseases Service, Instituto de Oncología Ángel H. Roffo, Buenos Aires C1417, Argentina.
José BensoInfectious Diseases Section, Internal Medicine Department, Hospital Italiano de San Justo, Buenos Aires C1198, Argentina.
María Luz González IbañezInfectious Diseases Service, Fundación para Combatir la Leucemia (FUNDALEU), Buenos Aires C1114, Argentina.
María José EusebioInfectious Diseases Service, Hospital Británico de Buenos Aires, Buenos Aires C1280, Argentina.
Nadia BaldoniInfectious Diseases Service, Hospital Interzonal General de Agudos (HIGA) Dr. Rodolfo Rossi, La Plata B1902, Argentina.
Laura Alicia BarcánInfectious Diseases Section, Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires C1199, Argentina.
Sandra LambertInfectious Diseases Service, Hospital El Cruce, Buenos Aires B1888, Argentina.
Martín LuckInfectious Diseases Service, Instituto de Oncología Ángel H. Roffo, Buenos Aires C1417, Argentina.
Fernando PasteránAntimicrobial Service, INEI-ANLIS Dr. Carlos Malbrán, Buenos Aires C1282, Argentina.ORCID 0000-0001-5840-5869
Alejandra CorsoAntimicrobial Service, INEI-ANLIS Dr. Carlos Malbrán, Buenos Aires C1282, Argentina.
Melina RapoportAntimicrobial Service, INEI-ANLIS Dr. Carlos Malbrán, Buenos Aires C1282, Argentina.
Federico NicolaMicrobiology Laboratory, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires C1431, Argentina.
María Cristina García DamianoMicrobiology Laboratory, Fundación para Combatir la Leucemia (FUNDALEU), Buenos Aires C1114, Argentina.
Renata MongeMicrobiology Service, Hospital Británico de Buenos Aires, Buenos Aires C1280, Argentina.
Ruth CarboneBacteriology Laboratory, Hospital Interzonal General de Agudos (HIGA) Prof. Dr. Rodolfo Rossi de La Plata, Buenos Aires B1902, Argentina.
Mariana ReynaldiMicrobiology Laboratory, Hospital Interzonal General de Agudos (HIGA), Gral. San Martín de La Plata, Buenos Aires B1900, Argentina.
Graciela GrecoBacteriology Laboratory, Hospital Italiano de Buenos Aires, Buenos Aires C1199, Argentina.
Miriam BlancoMicrobiology Laboratory, Hospital de Alta Complejidad El Cruce, Buenos Aires B1888, Argentina.
María Laura ChavesMicrobiology Laboratory, Hospital Municipal de Oncología Marie Curie, Buenos Aires C1405, Argentina.
Marcelo BronziMicrobiology Laboratory, Instituto de Oncología Ángel H. Roffo, Buenos Aires C1417, Argentina.
Alberto CarenaInfectious Diseases Section, Internal Medicine Department, Centro de Educación Médica e Investigaciones Clínicas, (CEMIC), Buenos Aires C1431, Argentina.
Argentine Group for the Study of Bacteremia in Cancer and Stem Cell Transplant (ROCAS)

Funding

Fundación Dr. Norberto Quirno ND
6 · The paper itself

Abstract

The epidemiology of bacteremia and the antibiotic resistance profile (ARP) of Gram-negative bacilli (GNB) in hematological malignancies (HM) and hematopoietic stem cell transplant (HSCT) patients may differ according to geographic region. In addition, multidrug-resistant organisms (MDROs) may impact mortality. This is a prospective, observational, and multicenter study. The first episodes of bacteremia in adult patients with HM or HSCT were included. The risk factors for 30-day mortality were identified. One thousand two hundred and seventy-seven episodes were included (HM: 920; HSCT: 357). GNB were isolated in 60.3% of episodes, with Enterobacterales (46.9%) and

Indexed as

Anti-Bacterial AgentsBacteremiaHematologic NeoplasmsHematopoietic Stem Cell TransplantationAdolescentAdultAgedArgentinaDrug Resistance, BacterialDrug Resistance, Multiple, BacterialFemaleGram-Negative BacteriaHumansMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial Agentsbacteremiaepidemiologyhematological malignanciesmortalityresistance

Identifiers

PMID39599486
PMCPMC11597762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.